skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
MART-1:27-35 Peptide Vaccine (Code C2775)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: MART-1:27-35 Peptide Vaccine

Definition: A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.

Display Name: MART-1:27-35 Peptide Vaccine

Label: MART-1:27-35 Peptide Vaccine

NCI Thesaurus Code: C2775 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1831795  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
MART-1:27-35 Peptide
MART-1:27-35 Peptide Vaccine

External Source Codes: 
NSC Code 672643 (see NCI DTP info)
PDQ Closed Trial Search ID 476336
PDQ Open Trial Search ID 476336 (check for NCI PDQ open clinical trial info)
UMLS CUI C1831795

Other Properties:
     Name Value (qualifiers indented underneath)
code C2775
Contributing_Source CTRP
Legacy_Concept_Name MART-1_27-35_PEPTIDE
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom